FIP works closely with the press to support accurate, timely and impactful reporting on pharmacy practice, pharmacy education and pharmaceutical science and global health developments. FIP provides journalists and media professionals with access to policy developments, research, publications, campaigns and initiatives shaping health care worldwide.
FIP also supports media engagement through dedicated press registration and press benefits during the annual FIP world congress, offering accredited journalists opportunities to access scientific sessions, interviews with global pharmacy leaders and key developments from across the profession.
If you would like to join our press list to receive press releases, please email press@fip.org with your name, publication, job title and email address.
The Hague • 17 October 2023
Regulating against medicines misinformation is among a number of recommendations to governments made by the International Pharmaceutical Federation (FIP) in a statement of policy on the strategic development of medicines information, published today.
“This statement of policy replaces one published by FIP in 2017, taking into account the increasing use of digital information sources, including artificial intelligence, and putting a stronger emphasis on the role of pharmacists to lead in this area,” said Dr Boyan Todorov, president of FIP’s Health and Medicines Information Section and co-chair of the policy committee that developed the statement.
Dr Todorov explained: “Medicines information is essential to empower patients, users of medicines, healthcare practitioners and caregivers to engage in the safe, effective and appropriate use of medicines. Challenges in ensuring the quality of information often relate to the decentralised and unsupervised ways of creating health and well-being information online. For example, users of medicines can now find information through artificial intelligence platforms, but that information can be incorrect, with detrimental effects on health.”
Pharmacists should utilise their expertise to lead the creation and execution of effective medicines information strategies, while establishing their role as a trusted partner and knowledge base for other healthcare practitioners, and as the primary resource for obtaining accurate and unbiased medicines information, FIP says. In particular, they should give special attention to the use of printed or electronic information to reinforce spoken information provided. In addition, the federation calls for the establishment of medicines information centres operated by pharmacists specialising in the provision of medicines information.
The updated statement of policy also contains a number of recommendations for action by other stakeholders, including education providers, the pharmaceutical industry and FIP member organisations.
Notes for editors
About FIP The International Pharmaceutical Federation (FIP) is the global federation of national associations of pharmacists, pharmaceutical scientists and pharmacy educators, and is in official relations with the World Health Organization. Through its 156 member organisations, it represents over four million practitioners and scientists around the world. www.fip.org
PRESS CONTACT
Ms Marina Llibre Martín
Communications Coordinator
International Pharmaceutical Federation (FIP)
Email marina@fip.org
Tel +31 70 302 1977